Confidential

Co-development and promotion for an insulin vial reader and blood glucose meter system
Co-development and supply agreement for slide coatings (and slide formats) with two different suppliers
Development and in-license for a combination insulin pen and blood glucose meter
Development, supply, and in-license of non-invasive, optical technology to measure advanced glycosylated end products
Diabetes disease management collaboration
Elimination of in-license and lab, and moved to FTO and OEM lab implementation for drug response prediction panel
Financial modeling and negotiation support for successful OEM deal by strategic partner for a novel biomarker company
Product development and commercialization agreement for multi-marker cardiac assay, including biomarker in-licensing and FTO
Product development and commercialization agreement for psychiatric pharmacogenomic assay, including biomarker in-licensing and FTO
Product development and commercialization agreement with specialized CLIA lab for custom diagnostic system
For large diagnostic division, screen of over 100 external and internal product concepts, including financial and technology assessment, as well as early new product development milestones
Miscellaneous acquisition bids, offerings, and due diligence, e.g., sale—revised strategy and financials for fluid power subsidiary (credited for sale price 2x of expectation), bid—market assessment and bid for industrial controls business (client satisfied with bid as believed the winning bid well overpaid), market assessment—for purchase of existing diagnostic instrument business (despite being pitched as still selling to the broad market, instrument had been marginalized to esoteric tests)
Multitude of gene licenses and material transfer agreements
Various assessments and negotiations with potential acquirers for private diagnostic and life science firm